Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1.

The human aldehyde dehydrogenase (ALDH) superfamily consists of at least 19 enzymes that metabolize endogenous and exogenous aldehydes. Currently, there are no commercially available inhibitors that target ALDH1A1 but have little to no effect on the structurally and functionally similar ALDH2. Here we present the first human ALDH1A1 structure, as the apo-enzyme and in complex with its cofactor NADH to a resolution of 1.75 and 2.1Å, respectfully. Structural comparisons of the cofactor binding sites in ALDH1A1 with other closely related ALDH enzymes illustrate a high degree of similarity. In order to minimize discovery of compounds that inhibit both isoenzymes by interfering with their conserved cofactor binding sites, this study reports the use of an in vitro, NAD(+)-independent, esterase-based high-throughput screen (HTS) of 64,000 compounds to discover novel, selective inhibitors of ALDH1A1. We describe 256 hits that alter the esterase activity of ALDH1A1. The effects on aldehyde oxidation of 67 compounds were further analyzed, with 30 selectively inhibiting ALDH1A1 compared to ALDH2 and ALDH3A1. One compound inhibited ALDH1A1 and ALDH2, while another inhibited ALDH1A1, ALDH2, and the more distantly related ALDH3A1. The results presented here indicate that this in vitro enzyme activity screening protocol successfully identified ALDH1A1 inhibitors with a high degree of isoenzyme selectivity. The compounds identified via this screen plus the screening methodology itself represent a starting point for the development of highly potent and selective inhibitors of ALDH1A1 that may be utilized to better understand the role of this enzyme in both normal and disease states.

[1]  P. Marcato,et al.  Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform , 2011, Cell cycle.

[2]  H. Baker,et al.  Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases. , 1998, Structure.

[3]  V. Vasiliou,et al.  The Aldehyde Dehydrogenase Gene Superfamily Resource Center , 2009, Human Genomics.

[4]  Lung-Ji Chang,et al.  The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. , 2012, Chemico-biological interactions.

[5]  Daria Mochly-Rosen,et al.  Discovery of a Novel Class of Covalent Inhibitor for Aldehyde Dehydrogenases* , 2011, The Journal of Biological Chemistry.

[6]  T. T. Wang,et al.  Cloning and expression of the full-length cDNAS encoding human liver class 1 and class 2 aldehyde dehydrogenase. , 1993, Alcoholism, clinical and experimental research.

[7]  C. Buchman,et al.  N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes. , 2015, Chemico-biological interactions.

[8]  O. Colvin,et al.  Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Riederer,et al.  Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study , 2012, Parkinson's disease.

[10]  J. Farrés,et al.  Investigation of the active site cysteine residue of rat liver mitochondrial aldehyde dehydrogenase by site-directed mutagenesis. , 1995, Biochemistry.

[11]  H. Weiner,et al.  Selective alteration of the rate-limiting step in cytosolic aldehyde dehydrogenase through random mutagenesis. , 2006, Biochemistry.

[12]  E. Rudiño-Piñera,et al.  The crystal structure of a ternary complex of betaine aldehyde dehydrogenase from Pseudomonas aeruginosa Provides new insight into the reaction mechanism and shows a novel binding mode of the 2'-phosphate of NADP+ and a novel cation binding site. , 2009, Journal of molecular biology.

[13]  M. Fishel,et al.  Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 (ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity , 2014, Chembiochem : a European journal of chemical biology.

[14]  D. Matei,et al.  Beta-Catenin Regulated ALDH1A1 is a Target in Ovarian Cancer Spheroids , 2014, Oncogene.

[15]  A. MacGibbon,et al.  Kinetic studies on the esterase activity of cytoplasmic sheep liver aldehyde dehydrogenase. , 1978, Biochemical Journal.

[16]  Jay Painter,et al.  Electronic Reprint Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion , 2005 .

[17]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[18]  B. Vallee,et al.  Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Hallenga,et al.  Multiple conformations of NAD and NADH when bound to human cytosolic and mitochondrial aldehyde dehydrogenase. , 2002, Biochemistry.

[20]  J. Haseman,et al.  Toxicology and carcinogenesis studies of microencapsulated citral in rats and mice. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  Y. Tsybovsky,et al.  Crystal structures of the carboxyl terminal domain of rat 10-formyltetrahydrofolate dehydrogenase: implications for the catalytic mechanism of aldehyde dehydrogenases. , 2007, Biochemistry.

[22]  M. Kastan,et al.  Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells , 1990 .

[23]  Jay Painter,et al.  Electronic Reprint Biological Crystallography a Molecular Viewer for the Analysis of Tls Rigid-body Motion in Macromolecules Biological Crystallography a Molecular Viewer for the Analysis of Tls Rigid-body Motion in Macromolecules , 2022 .

[24]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[25]  M. Disatnik,et al.  Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart , 2008, Science.

[26]  Yuh-Ju Sun,et al.  The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold , 1997, Nature Structural Biology.

[27]  D. Mochly‐Rosen,et al.  Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant , 2010, Nature Structural &Molecular Biology.

[28]  T. Hurley,et al.  Coenzyme isomerization is integral to catalysis in aldehyde dehydrogenase. , 2003, Biochemistry.

[29]  M. Fishel,et al.  Selective ALDH3A1 Inhibition by Benzimidazole Analogues Increase Mafosfamide Sensitivity in Cancer Cells , 2014, Journal of medicinal chemistry.

[30]  May Khanna,et al.  Discovery of novel regulators of aldehyde dehydrogenase isoenzymes. , 2011, Chemico-biological interactions.

[31]  Vindhya Koppaka,et al.  Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application , 2012, Pharmacological Reviews.

[32]  H. Weiner,et al.  Involvement of glutamate 268 in the active site of human liver mitochondrial (class 2) aldehyde dehydrogenase as probed by site-directed mutagenesis. , 1995, Biochemistry.

[33]  Anders Liljas,et al.  2 Evolutionary and Structural Relationships among Dehydrogenases , 1975 .

[34]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[35]  Richard J. Jones,et al.  Assessment of aldehyde dehydrogenase in viable cells. , 1995, Blood.

[36]  Dagmar Galter,et al.  ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia , 2003, Neurobiology of Disease.

[37]  Ashkan Emadi,et al.  Cyclophosphamide and cancer: golden anniversary , 2009, Nature Reviews Clinical Oncology.

[38]  J. Berger,et al.  Retinaldehyde represses adipogenesis and diet-induced obesity , 2007, Nature Medicine.